What kind of interaction is it?

Caution: an interaction that may reduce efficacy or raise side-effect risk and warrants monitoring.

Is this interaction backed by published research?

Yes. NutriStack lists 2 citation rows for the Alpha-Lipoic Acid + Dulaglutide pair, each linking to PubMed by PMID where available. Full sourcing methodology at https://nutristackapp.com/methodology/interactions.

Interaction databaseSupplement × PrescriptionReviewed May 2026

Alpha-Lipoic Acid and Dulaglutide, a caution.

Q: Can I take Alpha-Lipoic Acid and Dulaglutide together?

Possibly, but with caution. Alpha-Lipoic Acid and Dulaglutide have a documented caution-tier interaction. Alpha-lipoic acid improves insulin sensitivity and dulaglutide augments glucose-dependent insulin release. On dulaglutide alone the hypoglycemia risk is low, but additive effects can matter when ALA is added on top of insulin or a sulfonylurea. ALA has also rarely triggered insulin autoimmune syndrome with severe spontaneous hypoglycemia.

Q: How does this affect a NutriStack Stack Score?

-5 to your Stack Score per scored caution row.

Alpha-lipoic acid improves insulin sensitivity and dulaglutide augments glucose-dependent insulin release. On dulaglutide alone the hypoglycemia risk is low, but additive effects can matter when ALA is added on top of insulin or a sulfonylurea. ALA has also rarely triggered insulin autoimmune syndrome with severe spontaneous hypoglycemia.

2 primary source citations. Emerging evidence. Last verified May 30, 2026.

Open the interaction checker →Read the methodology

One pair, every claim cited. The two substances, the type, the mechanism, the recommendation, and the primary literature.
Same shape as the other 1,729 pairs in the public database.

Sourcing standards·Evidence tiers

From the interaction database

What the row says.

Every entry follows the same shape: what is happening, the mechanism, the recommendation, and the primary literature.

At a glance

Substances: Alpha-Lipoic Acid and Dulaglutide
Pair type: Caution
Evidence (highest tier): Emerging
Source citations: 2 sources
Stack Score effect: −5 to your Stack Score (per scored caution row).
Scope: Supplement × Prescription
Last verified: May 30, 2026

Caution · Emerging evidence

Caution

What is happening. Alpha-lipoic acid improves insulin sensitivity and dulaglutide augments glucose-dependent insulin release. On dulaglutide alone the hypoglycemia risk is low, but additive effects can matter when ALA is added on top of insulin or a sulfonylurea. ALA has also rarely triggered insulin autoimmune syndrome with severe spontaneous hypoglycemia.

Mechanism. Dulaglutide activates GLP-1 receptors, augmenting glucose-dependent insulin secretion and suppressing glucagon. ALA enhances insulin-stimulated GLUT4 translocation and AMPK activity. The mechanisms are complementary and additive.

Recommendation. If dulaglutide is your only diabetes medication, ALA can be added with home glucose monitoring for the first 2-4 weeks. If you also take insulin or a sulfonylurea, ask your prescriber whether the other agent needs a dose reduction first.

Sources (2)

Stack Score

How this pair moves the number.

Effect on the composite score

If both Alpha-Lipoic Acid and Dulaglutide are in the same stack, this pair applies −5 to your Stack Score (per scored caution row).

The full algorithm, the clamping rules, and four worked stacks are documented at /methodology/stack-score.

Check your full routine

One pair was the worked example. NutriStack runs every pair in your stack at once.

Drop in your supplements and prescriptions and the public database surfaces every interaction, synergy, timing rule, and contraindication, every one linked to its primary source.

Open the interaction checker →Browse the full research index